227 related articles for article (PubMed ID: 6252575)
1. Post-conceptional induction of menses with a single vaginal suppository of (15S)-15-methyl prostaglandin F2 alpha methyl ester.
Scher J; Jeng DY; Kerenyi TD
Prostaglandins; 1980 Sep; 20(3):469-79. PubMed ID: 6252575
[TBL] [Abstract][Full Text] [Related]
2. Termination of early gestation with a single vaginal suppository of (15S)-15-methyl-prostaglandin F2alpha methyl ester.
Roy S; Brenner PF; Marrs RP; Mishell DR
Contraception; 1980 Aug; 22(2):137-52. PubMed ID: 7449379
[TBL] [Abstract][Full Text] [Related]
3. Termination of very early pregnancy by vaginal suppositories-(15S)-15-methyl prostaglandin F2 alpha methyl ester.
Wan LS; Stiber AJ; Turkel J
Contraception; 1981 Dec; 24(6):603-15. PubMed ID: 6173156
[TBL] [Abstract][Full Text] [Related]
4. Termination of early gestation with (15S)-15-methyl prostaglandin F2 alpha methyl ester vaginal suppositories.
Marrs RP; Brenner PF; Roy S; Mishell DR
Contraception; 1981 Dec; 24(6):617-30. PubMed ID: 6173157
[TBL] [Abstract][Full Text] [Related]
5. Termination of early pregnancy by a single-dose 3.0 mg 15-methyl PGF2alpha methyl ester vaginal suppository.
Mandelin M
Prostaglandins; 1978 Jul; 16(1):143-52. PubMed ID: 704921
[TBL] [Abstract][Full Text] [Related]
6. Postconceptional induction of menses with double prostaglandin F2 alpha impact.
Borten M; Friedman EA
Am J Obstet Gynecol; 1984 Dec; 150(8):1006-7. PubMed ID: 6507528
[TBL] [Abstract][Full Text] [Related]
7. Menses induction and second-trimester pregnancy termination using a polymeric controlled release vaginal delivery system containing (15S)15-methyl PGF2 alpha methyl ester.
Bygdeman M; Christenssen N; Gréen K; Vesterqvist O; Roseman TJ; Tuttle ME; Spilman CH
Contraception; 1983 Feb; 27(2):141-51. PubMed ID: 6303690
[TBL] [Abstract][Full Text] [Related]
8. Termination of early gestation with 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2.
Brenner PF; Marrs RP; Roy S; Mishell DR
Contraception; 1982 Sep; 26(3):261-77. PubMed ID: 6184197
[TBL] [Abstract][Full Text] [Related]
9. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
Puri CP; Laumas V; Agarwal N; Zoremthangi ; Hingorani V; Laumas KR
Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
[TBL] [Abstract][Full Text] [Related]
10. Vaginal administration of 15-methyl-PGF2 alpha methyl ester for preoperative cervical dilatation. Task force on prostaglandins for fertility regulation. The World Health Organization.
Contraception; 1981 Mar; 23(3):251-9. PubMed ID: 7016432
[TBL] [Abstract][Full Text] [Related]
11. Menstrual regulation with prostaglandin (Pg ONO 802) in Indonesia.
Agoestina T; Sastrawinata S; Prayitno W; Gonta P
Int J Gynaecol Obstet; 1984 Oct; 22(5):403-9. PubMed ID: 6151928
[TBL] [Abstract][Full Text] [Related]
12. The effect of a 15(S)-15-methyl prostaglandin F2 alpha (methyl ester) suppository upon termination of early pregnancy.
Roux JF; Southern E; Gutknecht G
Contraception; 1980 Jul; 22(1):57-61. PubMed ID: 7418407
[TBL] [Abstract][Full Text] [Related]
13. Early abortion by vaginal prostaglandin suppositories. Blood loss in relation to elimination of serum chorionic gonadotrophin, progesterone and estradiol-17 beta.
Hamberger L; Nilsson L; Björn-Rasmussen E; Atterfelt P; Wiqvist N
Contraception; 1978 Feb; 17(2):183-93. PubMed ID: 630888
[TBL] [Abstract][Full Text] [Related]
14. Termination of second trimester pregnancy with a long-acting vaginal pessary containing 15-methyl-PGF2 alpha methyl ester.
Int J Gynaecol Obstet; 1983 Apr; 21(2):159-65. PubMed ID: 6136437
[TBL] [Abstract][Full Text] [Related]
15. Methods to determine success of attempts to terminate early gestation pregnancies with prostaglandin vaginal suppositories.
Brenner PF; Marrs RP; Roy S; Mishell DR
Contraception; 1983 Aug; 28(2):111-24. PubMed ID: 6196152
[TBL] [Abstract][Full Text] [Related]
16. Interruption of pregnancy with vaginal suppositories containing 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester.
Wagatsuma T; Tabuchi T; Tabei T; Kaku R
Contraception; 1979 Jun; 19(6):591-7. PubMed ID: 487809
[TBL] [Abstract][Full Text] [Related]
17. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
Nilsson S; Zador G; Nygren KG; Wide L
Gynecol Obstet Invest; 1981; 12(4):203-10. PubMed ID: 7250783
[TBL] [Abstract][Full Text] [Related]
18. Menses induction in rhesus monkeys using a controlled-release vaginal delivery system containing (15S) 15-methyl prostaglandin F2 alpha methyl ester.
Spilman CH; Beuving DC; Forbes AD; Roseman TJ; Bennett RM; Biermacher JJ; Tuttle ME
Fertil Steril; 1984 Oct; 42(4):638-43. PubMed ID: 6489542
[TBL] [Abstract][Full Text] [Related]
19. The vaginal administration of 9-deoxo-16,16-dimethyl-9-methylene PGE2 for second trimester abortion.
Ballard CA
Contraception; 1981 Aug; 24(2):151-7. PubMed ID: 7297067
[TBL] [Abstract][Full Text] [Related]
20. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
Borten M; DiLeo LA; Friedman EA
Am J Obstet Gynecol; 1984 Nov; 150(5 Pt 1):561-5. PubMed ID: 6496588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
